279 related articles for article (PubMed ID: 16507132)
21. P-glycoprotein mediates resistance to A3 adenosine receptor agonist 2-chloro-N6-(3-iodobenzyl)-adenosine-5'-n-methyluronamide in human leukemia cells.
Mlejnek P; Dolezel P; Kosztyu P
J Cell Physiol; 2012 Feb; 227(2):676-85. PubMed ID: 21520073
[TBL] [Abstract][Full Text] [Related]
22. Calbindin-D28K expression induced by glial cell line-derived neurotrophic factor in substantia nigra neurons dependent on PI3K/Akt/NF-kappaB signaling pathway.
Wang HJ; Cao JP; Yu JK; Zhang LC; Jiang ZJ; Gao DS
Eur J Pharmacol; 2008 Oct; 595(1-3):7-12. PubMed ID: 18703048
[TBL] [Abstract][Full Text] [Related]
23. Radiation-enhanced hepatocellular carcinoma cell invasion with MMP-9 expression through PI3K/Akt/NF-kappaB signal transduction pathway.
Cheng JC; Chou CH; Kuo ML; Hsieh CY
Oncogene; 2006 Nov; 25(53):7009-18. PubMed ID: 16732316
[TBL] [Abstract][Full Text] [Related]
24. Clinical evidence for utilization of the A3 adenosine receptor as a target to treat rheumatoid arthritis: data from a phase II clinical trial.
Silverman MH; Strand V; Markovits D; Nahir M; Reitblat T; Molad Y; Rosner I; Rozenbaum M; Mader R; Adawi M; Caspi D; Tishler M; Langevitz P; Rubinow A; Friedman J; Green L; Tanay A; Ochaion A; Cohen S; Kerns WD; Cohn I; Fishman-Furman S; Farbstein M; Yehuda SB; Fishman P
J Rheumatol; 2008 Jan; 35(1):41-8. PubMed ID: 18050382
[TBL] [Abstract][Full Text] [Related]
25. Treatment with N-tosyl-l-phenylalanine chloromethyl ketone after the onset of collagen-induced arthritis reduces joint erosion and NF-kappaB activation.
Choi J; Ha KH; Byun MS; Min SY; Park MJ; Park HS; Oh HJ; Ju JH; Kim HY; Jue DM
Eur J Pharmacol; 2008 Oct; 595(1-3):108-13. PubMed ID: 18706406
[TBL] [Abstract][Full Text] [Related]
26. The phosphatidylinositol 3-kinase/Akt pathway negatively regulates Nod2-mediated NF-kappaB pathway.
Zhao L; Lee JY; Hwang DH
Biochem Pharmacol; 2008 Apr; 75(7):1515-25. PubMed ID: 18243161
[TBL] [Abstract][Full Text] [Related]
27. A novel, highly selective, tight binding IkappaB kinase-2 (IKK-2) inhibitor: a tool to correlate IKK-2 activity to the fate and functions of the components of the nuclear factor-kappaB pathway in arthritis-relevant cells and animal models.
Mbalaviele G; Sommers CD; Bonar SL; Mathialagan S; Schindler JF; Guzova JA; Shaffer AF; Melton MA; Christine LJ; Tripp CS; Chiang PC; Thompson DC; Hu Y; Kishore N
J Pharmacol Exp Ther; 2009 Apr; 329(1):14-25. PubMed ID: 19168710
[TBL] [Abstract][Full Text] [Related]
28. Tumor necrosis factor-alpha regulates inflammatory and mesenchymal responses via mitogen-activated protein kinase kinase, p38, and nuclear factor kappaB in human endometriotic epithelial cells.
Grund EM; Kagan D; Tran CA; Zeitvogel A; Starzinski-Powitz A; Nataraja S; Palmer SS
Mol Pharmacol; 2008 May; 73(5):1394-404. PubMed ID: 18252806
[TBL] [Abstract][Full Text] [Related]
29. cis-9,trans-11-conjugated linoleic acid down-regulates phorbol ester-induced NF-kappaB activation and subsequent COX-2 expression in hairless mouse skin by targeting IkappaB kinase and PI3K-Akt.
Hwang DM; Kundu JK; Shin JW; Lee JC; Lee HJ; Surh YJ
Carcinogenesis; 2007 Feb; 28(2):363-71. PubMed ID: 16950795
[TBL] [Abstract][Full Text] [Related]
30. 1,25-dihydroxyvitamin D3 induces biphasic NF-kappaB responses during HL-60 leukemia cells differentiation through protein induction and PI3K/Akt-dependent phosphorylation/degradation of IkappaB.
Tse AK; Wan CK; Shen XL; Zhu GY; Cheung HY; Yang M; Fong WF
Exp Cell Res; 2007 May; 313(8):1722-34. PubMed ID: 17397830
[TBL] [Abstract][Full Text] [Related]
31. Thymulin and zinc (Zn2+)-mediated inhibition of endotoxin-induced production of proinflammatory cytokines and NF-kappaB nuclear translocation and activation in the alveolar epithelium: unraveling the molecular immunomodulatory, anti-inflammatory effect of thymulin/Zn2+ in vitro.
Haddad JJ
Mol Immunol; 2009 Dec; 47(2-3):205-14. PubMed ID: 19850345
[TBL] [Abstract][Full Text] [Related]
32. CT20126, a novel immunosuppressant, prevents collagen-induced arthritis through the down-regulation of inflammatory gene expression by inhibiting NF-kappaB activation.
Lee SJ; Nam WD; Na HJ; Cho YL; Ha KS; Hwang JY; Lee H; Kim SO; Kwon YG; Kim YM
Biochem Pharmacol; 2008 Jul; 76(1):79-90. PubMed ID: 18513703
[TBL] [Abstract][Full Text] [Related]
33. Enhancing pigmentation via activation of A3 adenosine receptors in B16 melanoma cells and in human skin explants.
Madi L; Rosenberg-Haggen B; Nyska A; Korenstein R
Exp Dermatol; 2013 Jan; 22(1):74-7. PubMed ID: 23088669
[TBL] [Abstract][Full Text] [Related]
34. VEGF is upregulated by hypoxia-induced mitogenic factor via the PI-3K/Akt-NF-kappaB signaling pathway.
Tong Q; Zheng L; Lin L; Li B; Wang D; Huang C; Li D
Respir Res; 2006 Mar; 7(1):37. PubMed ID: 16512910
[TBL] [Abstract][Full Text] [Related]
35. An adenosine analog (IB-MECA) inhibits anchorage-dependent cell growth of various human breast cancer cell lines.
Panjehpour M; Karami-Tehrani F
Int J Biochem Cell Biol; 2004 Aug; 36(8):1502-9. PubMed ID: 15147729
[TBL] [Abstract][Full Text] [Related]
36. Cyclosporine A inhibits IL-15-induced IL-17 production in CD4+ T cells via down-regulation of PI3K/Akt and NF-kappaB.
Cho ML; Ju JH; Kim KW; Moon YM; Lee SY; Min SY; Cho YG; Kim HS; Park KS; Yoon CH; Lee SH; Park SH; Kim HY
Immunol Lett; 2007 Jan; 108(1):88-96. PubMed ID: 17161467
[TBL] [Abstract][Full Text] [Related]
37. Sphingosine-1-phosphate induces COX-2 expression via PI3K/Akt and p42/p44 MAPK pathways in rat vascular smooth muscle cells.
Hsieh HL; Wu CB; Sun CC; Liao CH; Lau YT; Yang CM
J Cell Physiol; 2006 Jun; 207(3):757-66. PubMed ID: 16508949
[TBL] [Abstract][Full Text] [Related]
38. Adenosine A2A receptor agonists inhibit lipopolysaccharide-induced production of tumor necrosis factor-alpha by equine monocytes.
Sun WC; Moore JN; Hurley DJ; Vandenplas ML; Linden J; Cao Z; Murray TF
Vet Immunol Immunopathol; 2008 Jan; 121(1-2):91-100. PubMed ID: 17913243
[TBL] [Abstract][Full Text] [Related]
39. Insulin regulates P-glycoprotein in rat brain microvessel endothelial cells via an insulin receptor-mediated PKC/NF-kappaB pathway but not a PI3K/Akt pathway.
Liu H; Yang H; Wang D; Liu Y; Liu X; Li Y; Xie L; Wang G
Eur J Pharmacol; 2009 Jan; 602(2-3):277-82. PubMed ID: 19049803
[TBL] [Abstract][Full Text] [Related]
40. Use of molecular imaging to quantify response to IKK-2 inhibitor treatment in murine arthritis.
Izmailova ES; Paz N; Alencar H; Chun M; Schopf L; Hepperle M; Lane JH; Harriman G; Xu Y; Ocain T; Weissleder R; Mahmood U; Healy AM; Jaffee B
Arthritis Rheum; 2007 Jan; 56(1):117-28. PubMed ID: 17195214
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
